𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term sequential deferiprone–deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial

✍ Scribed by Aurelio Maggio; Angela Vitrano; Marcello Capra; Liana Cuccia; Francesco Gagliardotto; Aldo Filosa; Maria Antonietta Romeo; Carmelo Magnano; Vincenzo Caruso; Crocetta Argento; Calogera Gerardi; Saveria Campisi; Pietro Violi; Roberto Malizia; Paolo Cianciulli; Michele Rizzo; Domenico Giuseppe D’Ascola; Alessandra Quota; Luciano Prossomariti; Carmelo Fidone; Paolo Rigano; Alessia Pepe; Gennaro D’Amico; Alberto Morabito; Christian Gluud

Book ID
108676215
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
272 KB
Volume
145
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized trial of long term adjuvant
A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery
✍ Kristina Dalberg; Hemming Johansson; Ulla Johansson; Lars E. Rutqvist 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w

A randomized trial of hybrid administrat
A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/Cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma : Results of long term follow-up
✍ Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Haruhito Kamei; Kenichi Gemba; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

## BACKGROUND. In an attempt to determine the efficacy of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) hybrid chemotherapy (HYB), a rapidly alternating chemotherapy, in patients with small cell lung carcinoma (SCLC), the authors conducted a randomized study to